IDH1 and glioblastoma: NPV was lower for IDH-wt GBM (74.2% ± 8.9%) when compared to both IDH-mut 1p/19q codeleted ODG (94.9% ± 6.9%) and IDH-mut astrocytoma (96.5% ± 2.5%).